SCM
DMIIR

Shaolin Capital Management’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Shaolin Capital Management’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.2K Buy
402,368
+27,368
+7% +$2.34K ﹤0.01% 524
2026
Q1 		$30K Sell
375,000
-150,000
-29% -$17K ﹤0.01% 467
2025
Q4 		$73.5K Buy
+525,000
New +$75K ﹤0.01% 342

Other funds holding DMIIR

MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

Shaolin Capital Management's DMIIR Position: Q2 2026 in Review

Shaolin Capital Management increased its Drugs Made In America Acquisition II Corp Right (DMIIR) stake by 7.3% in Q2 2026, buying an estimated $2.34K and bringing the position to 402,368 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #524.

Shaolin Capital Management first reported a position in DMIIR in Q4 2025 and has held it in 3 quarters since. The position peaked at $73.5K in Q4 2025. 62 funds tracked by Wall St. Rank hold DMIIR as of Q2 2026.

  • Shaolin Capital Management held 402,368 shares of Drugs Made In America Acquisition II Corp Right worth $32.2K as of Q2 2026.
  • Shaolin Capital Management bought 27,368 Drugs Made In America Acquisition II Corp Right shares in Q2 2026, an estimated $2.34K.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Shaolin Capital Management's portfolio in Q2 2026, its #524 holding.
  • Shaolin Capital Management first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 3 quarters since.
  • Shaolin Capital Management's Drugs Made In America Acquisition II Corp Right position peaked at $73.5K in Q4 2025.
  • 62 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q2 2026.

Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.